Table 2. Anthropometric Indices, Biochemical Measurements, Blood Pressure and Dietary Intake of Study Participants (After Intervention)a.
Variable | Placebo Group | n-3 PUFA Group | P Valueb |
---|---|---|---|
(N = 21), | (N = 22), | ||
(M = 13, F = 8) | (M = 12, F = 10) | ||
Weight, kg | 79.26 ± 2.07 | 79.44 ± 2.31 | 0.956 |
BMI, kg/m 2 | 29.08 ± 0.45 | 28.28 ± 0.47 | 0.232 |
WC, cm | 103.96 ± 1.73 | 99.87 ± 1.47 | 0.741 |
HC, cm | 105.9 ± 5.8 | 105.4 ± 1.0 | 0.609 |
WHR | 0.98 ± 0.01 | 0.94 ± 0.01 | 0.064 |
FBS, mg/dL | 1.70 ± 9.10 | 1.57 ± 9.88 | 0.327 |
Insulin, µm/mL | 12.52 ± 0.90 | 10.22 ± 0.88 | 0.076 |
HbA1C, % | 7.64 ± 0.20 | 7.10 ± 0.22 | 0.80 |
HOMA.IR, % | 5.62 ± 0.55 | 4.09 ± 0.50 | 0.047 |
Serum Irisin, µg/mL | 1.72 ± 0.35 | 3.61 ± 0.82 | 0.043 |
Systolic BP, mmHg | 130.2 ± 2.2 | 127.1 ± 1.7 | 0.27 |
Diastolic BP, mmHg | 86.00 ± 1.86 | 81.45 ± 1.19 | 0.04 |
Total energy, kcal | 2091 ± 51 | 2088 ± 43 | 0.97 |
Total protein, g | 67.48 ± 3.48 | 73.03 ± 3.73 | 0.28 |
Total fat, g | 82.18 ± 3.94 | 79.88 ± 2.53 | 0.62 |
Total carbohydrate, g | 276 ± 9 | 275 ± 7 | 0.9 |
DHA, g | 0.08 ± 0.04 | 0.19 ± 0.1 | 0.34 |
EPA, g | 0.03 ± 0.01 | 0.06 ± 0.03 | 0.37 |
Abbreviations: BMI, body mass index; BP, blood pressure; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; F, female; HC, hip circumference; M, male; WC, waist circumference; WHR, waist-to-hip ratio.
aValues are described as mean ± standard error (SE).
bIndependent sample t-test.